Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;152(5):983-986.e6.
doi: 10.1053/j.gastro.2016.12.010. Epub 2016 Dec 23.

Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer

Collaborators, Affiliations

Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer

Ruta Sahasrabudhe et al. Gastroenterology. 2017 Apr.

Abstract

Up to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) not associated with mutations in CDH1 and performed whole-exome sequence analysis. We then analyzed sequences of candidate genes in 333 independent HDGC and non-HDGC cases. We identified 11 cases with mutations in PALB2, BRCA1, or RAD51C genes, which regulate homologous DNA recombination. We found these mutations in 2 of 31 patients with HDGC (6.5%) and 9 of 331 patients with sporadic gastric cancer (2.8%). Most of these mutations had been previously associated with other types of tumors and partially co-segregated with gastric cancer in our study. Tumors that developed in patients with these mutations had a mutation signature associated with somatic homologous recombination deficiency. Our findings indicate that defects in homologous recombination increase risk for gastric cancer.

Keywords: Interaction; Stomach; Tumor; WES.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflict of interest to disclose.

Comment in

References

    1. Ferlay J. Int J Cancer. 2015;136:E359–86. - PubMed
    1. La Vecchia C. Cancer. 1992;70:50–5. - PubMed
    1. Guilford P. Nature. 1998;392:402–5. - PubMed
    1. Hansford S. JAMA Oncol. 2015;1:23–32. - PubMed
    1. Prakash R. Cold Spring Harb Perspect Biol. 2015;7:a016600. - PMC - PubMed

Publication types